So, You Got a First-Pass TEA Model from an AI Tool, Digital Twin, or Template. But Are the Outputs Useful, Traceable, and Defensible?

AI and digital tools can help founders get started faster. The next step is making sure the results can actually support R&D decisions, fundraising, CMO discussions, and scale-up strategy.

Recently, I have been getting a growing number of biotech, foodtech, and sustainable materials startups coming to me with a first-pass techno-economic analysis already in hand.

Sometimes it was built with an AI tool. Sometimes it came from a digital twin platform. Sometimes it was developed using an accelerator spreadsheet template, shared through an incubator programme.

And in many cases, the result is a useful starting point.

It helps the team visualize the process, organize assumptions, compare scales, and begin to understand what their unit economics might look like.

I think this is a positive development.

For a long time, many early-stage companies delayed techno-economic analysis until very late in development. They focused on the science, the strain, the formulation, the extraction route, the prototype, or the pilot trial, and only later asked the economic questions.

• Can this process ever be cost competitive?

• What production volume would make sense?

• Which technology or processing route could make sense at industrial scale?

So anything that helps founders think earlier about scale, unit economics, capital intensity, and cost drivers is valuable.

But there is one important caveat.

An AI-generated, digital twin, or template-based TEA is not automatically investor-ready.

If this sounds familiar if your startup already has a first-pass TEA model and you are not fully sure whether the outputs are robust enough to guide R&D decisions, fundraising, CMO conversations, or scale-up strategy this is exactly the kind of situation where an independent TEA review can be useful.

The goal is not necessarily to start again from zero. Often, the value is in taking what already exists, reviewing it with an experienced TEA lens, and turning it into something clearer, more useful, and more defensible for the decisions ahead.

---

Most first-pass TEA models I review can produce a number. They can estimate cost of goods. They can show a pilot-scale case and a commercial-scale case. They can even generate nice-looking charts.

But the real question is not whether the model produces an answer.

The real question is whether that answer is useful, traceable, and defensible.

That distinction matters.

Because a TEA is not just a spreadsheet. It is not just a cost number. And it is definitely not just a slide in an investor deck.

A proper techno-economic analysis should not only present an economic result. It should allow the team, investors, and technical partners to understand the level of confidence behind that result. In practice, that means the model needs to distinguish clearly between validated data, assumptions, extrapolations, and open uncertainties, without overstating what the current evidence can support.

This is where many first-pass models need a second layer of expert review.

Not necessarily because they are wrong.

But because they are often not yet structured in a way that can support technical decisions, investor conversations, or scale-up planning.

The issue is usually not the tool. AI-based TEA tools, digital twins, and automated modelling platforms can be genuinely helpful. They can help startups move faster, organize information, create a first process structure, and make founders aware of scale-up economics earlier.

That is all valuable.

The risk comes when a first-pass model is treated as if it were already a decision-ready TEA.

---

At early stage, many models naturally combine early data, optimistic assumptions, engineering extrapolations, and commercial-scale estimates. That is not unusual. The problem is when those different levels of confidence are blended into one polished base case without enough context.

That can create a false sense of precision.

And in fundraising, false precision can be dangerous.

A polished model may look convincing in a pitch deck. But a technical investor, strategic partner, or experienced advisor will usually go beyond the headline number. They will want to understand how robust the economics are, where the uncertainty sits, and whether the company has tested the assumptions that could materially change the business case.

These are not hostile questions. They are normal diligence questions.

A startup does not need to have perfect answers to all of them. But it does need to show that it understands the uncertainty and has a credible way to interpret the current model outputs.

That is the difference between a model that looks good and a model that is actually useful.

---

One of the most common concerns I hear from early-stage teams is that they are “not ready” for a TEA yet.

They are waiting for more data. More lab results. More pilot work. A clearer process route. A stronger technical package. Sometimes they are waiting for the next fundraising round before doing the analysis that could actually help them prepare for that round.

And I understand the hesitation.

But that does not mean it is too early for TEA thinking.

It is rarely too early for a TEA. It is only too early for the wrong type of TEA.

A TEA can be scoped to the maturity of the technology.

At an early stage, the right analysis may be directional. Later, it may become a more detailed scenario analysis to support R&D priorities. Later still, it may evolve into a more complete model to support CMO discussions, scale-up planning, investor due diligence, or fundraising.

The mistake is waiting until every technical question is answered before looking at the economics.

By then, the company may have already spent significant time and money optimizing things without knowing whether those improvements actually change the business case.

This is why a TEA should not compete with R&D.

A TEA should guide R&D.

It should help the team understand which technical and economic assumptions are most important to the business case, and which ones are secondary.

This matters because R&D resources are always limited.

A startup can spend months improving a technical parameter that looks scientifically important but has limited impact on the business case. At the same time, it may overlook another area that has a much larger effect on margin, capital intensity, scale-up risk, or investor confidence.

A good TEA helps avoid that.

It creates a bridge between the lab and the business case.

---

Of course, TEAs are not free. For an early-stage company, a proper techno-economic analysis can feel expensive. Founders are already balancing lab work, salaries, pilot trials, legal costs, IP strategy, regulatory questions, conferences, investor materials, and business development.

But the right way to think about a TEA is not as a spreadsheet or a report.

A TEA is a strategic decision-making tool.

Startups routinely invest in pitch decks, fundraising support, legal work, patents, pilot experiments, and technical development. All of those investments can be important. But a TEA should sit at the same strategic level, because it helps answer some of the most important questions for any industrial biotech, foodtech, or sustainable materials company:

What needs to be true technically, economically, and commercially for this business to work at scale?

That question is not only technical. It connects process performance, production scale, capital requirements, cost structure, pricing, business model, fundraising strategy, and commercial positioning. A good TEA helps founders understand which technical improvements actually matter, but also how those improvements translate into business decisions.

A well-structured TEA can pay for itself many times over if it helps a company avoid one unnecessary technical detour, prioritize the right experiments, identify the real economic drivers, or enter investor conversations with a more credible scale-up story.

It can also help founders avoid spending months building around a process assumption that later becomes a major economic bottleneck.

That is why TEA should not be seen only as something to prepare before a fundraising round.

It should be part of how the company decides what to do before the fundraising round.

---

For startups that already have an AI-generated model, a digital twin output, an internal spreadsheet, or an accelerator-generated TEA, the next step is not always to start again from zero.

Often, the better next step is to strengthen what already exists through an independent review.

The goal is not to make the model more complex. The goal is to understand whether the outputs are robust enough for the decision the company wants to make, whether that decision relates to R&D priorities, CMO conversations, fundraising, or scale-up strategy.

This does not mean making the model more pessimistic.

It means making it more useful.

A strong TEA gives context to the number. It helps the team understand what can be said confidently today, what still depends on assumptions, and what needs to be validated before the model is used for higher-stakes decisions.

In early-stage technology development, a TEA is rarely about proving that everything is already solved.

It is about asking better questions.

• What needs to be true for this process to be commercially viable?

• What level of confidence do we have in the current numbers?

• What should be shown externally, and what should remain an internal assumption?

• What decisions can be made now, and which ones require more evidence?

That is the real value of techno-economic analysis.

Not the spreadsheet.

Not the final cost number.

Not the nice chart in the pitch deck.

The real value is helping technical and commercial teams make better decisions with imperfect information.

AI tools and digital platforms will continue to improve. They will make TEA more accessible, faster, and more common across early-stage companies.

That is a good thing.

But for startups preparing for fundraising, scale-up, CMO discussions, or strategic partnerships, the key question remains:

Can you trust the model outputs enough to make decisions?

That is where independent TEA review becomes valuable.

Not to replace the model.

Not to criticize the tool.

But to turn a first-pass analysis into something clearer, more traceable, and more useful for decision-making.

So if your startup recently got a TEA model whether it was built internally, through an AI tool, a digital twin platform, or an accelerator programme the next step may not be to start again from scratch.

The next step may be to review it independently, stress-test the outputs, and translate the results into a more defensible economic narrative.

Because in the end, the question is not whether you have a model.

The question is whether the outputs are useful, traceable, and defensible enough to support the decisions ahead.

If you are wondering whether your current TEA model is ready to support R&D decisions, fundraising, CMO discussions, or scale-up strategy, feel free to reach out.

You may not need to start again from zero. You may simply need an independent TEA review to understand what the model can support today, where the uncertainty sits, and how to use the results with more confidence.